Archive · 17 Sep 2025
UK Opioid Crisis: Deaths Underreported, Crisis Worsening
Imagine the UK is facing a serious problem with drugs, especially opioids like heroin.
A new study says the official numbers of people dying from these drugs are too low.
The government collects data from coroners, but this method misses some important details about which drugs caused deaths.
The real number of deaths might be much higher than reported, and this problem could be getting worse because of new, very powerful drugs called nitazenes.
These drugs are often mixed with other drugs, and users are frequently unaware that they are consuming these, increasing the risk of overdose.
The government is trying to fix the problem by cracking down on these drugs and trying to collect more accurate information.
A new report indicates opioid-related deaths are significantly higher than official statistics.
Official data from the ONS underestimates deaths due to the limitations of current data collection.
The UK has the largest heroin market in Europe.
New synthetic opioids, like nitazenes, are a growing threat due to high potency and easy alteration.
Governments are working to improve data and control new substances.
- Who
- The report by King's College London and the ONS.
- What
- The number of opioid-related deaths in the UK has been underreported.
- When
- Between 2011 and 2022.
- Where
- Primarily in England and Wales, with a different system in Scotland.
- Why
- Official statistics don't accurately reflect substance-specific deaths due to data collection limitations.
- Report Findings
- Opioid-related deaths 50% higher than official ONS data (2011-2022)
- Official Data Source
- Office for National Statistics (ONS) in England and Wales; National Records of Scotland (NRS) in Scotland
- Heroin Market
- UK has largest heroin market in Europe with ~300,000 users in England alone
- Nitazenes
- Fastest-growing group of new psychoactive substances; potentially lethal
- Nitazene Potency
- 50 times more potent than heroin
- UK Government Action
- Controlling 15 synthetic opioids as Class A drugs (May 2024)